Vaccinex, Inc. Announces the First Patient Treated in a Phase Ib/II Combination Study with Anti-Semaphorin 4D Antibody, VX15/2503, and Avelumab in Non-Small Cell Lung Cancer Patients (CLASSICAL – Lung)
October 26, 2017 10:23 ET
|
Vaccinex, Inc.
ROCHESTER, N.Y., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Vaccinex Inc. today announced the dosing of the first patient in a Phase Ib/II study of VX15/2503, an investigational humanized anti-semaphorin 4D...
BluePrint Phase 2 Demonstrates Digital Pathology Review Equivalent to Glass Slides
October 17, 2017 21:45 ET
|
Histogenex LLC
YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- The BluePrint Phase 2 committee today presented its findings comparing five PD-L1 IHC assays at the International Association for the Study of Lung...
World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions
October 17, 2017 02:08 ET
|
IASLC
YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Today’s press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) featured...
World Conference on Lung Cancer Monday Press Conference: Dangers of Smoking and Lung Cancer Intervention Research
October 16, 2017 02:40 ET
|
IASLC
YOKOHAMA, Japan, Oct. 16, 2017 (GLOBE NEWSWIRE) -- At today’s press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC), the...
World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines
October 15, 2017 03:25 ET
|
IASLC
YOKOHAMA, Japan, Oct. 15, 2017 (GLOBE NEWSWIRE) -- The first press briefing at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC)...
The International Association for the Study of Lung Cancer Announces Abstract Selections for the 18th World Conference on Lung Cancer
September 07, 2017 14:00 ET
|
IASLC
DENVER, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The International Association for the Study of Lung Cancer (IASLC) announced today the abstract selections for the 18th World Conference on Lung Cancer...
The International Association for the Study of Lung Cancer Announces the IASLC 18th World Conference on Lung Cancer
July 13, 2017 12:01 ET
|
IASLC
DENVER, July 13, 2017 (GLOBE NEWSWIRE) -- The International Association for the Study of Lung Cancer (IASLC) announced today that the IASLC 18th World Conference on Lung Cancer (WCLC) will take...
Qu Biologics invited to present at US National Cancer Institute (NCI) Conference
July 12, 2017 17:06 ET
|
Qu Biologics
VANCOUVER, British Columbia, July 12, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Lung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy
July 10, 2017 13:09 ET
|
Biodesix, Inc.
BOULDER, Colo., July 10, 2017 (GLOBE NEWSWIRE) -- Clinical findings published in the peer reviewed journal Lung Cancer show that the Biodesix® VeriStrat test is prognostic for outcomes in patients...
bioAffinity Technologies Adds Four Scientists to Research & Commercialization Team
June 28, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, June 28, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early stage cancer diagnostics and precision cancer therapeutics, today announced four...